AEGiS-Glasgow [PL8.3] Vaccine preparedness: building up an enabling environment for AIDS vaccines clinical research

Seventh International Congress on Drug Therapy in HIV Infection

Glasgow, UK - 14-17 November 2004

[PL8.3] Vaccine preparedness: building up an enabling environment for AIDS vaccines clinical research

Int Cong Drug Therapy HIV 2004 Nov 14-18;7:Abstract No. PL8.3

Maite Suarez
International AIDS Vaccine Initiative, Amsterdam, The Netherlands

The goal of the International AIDS vaccines Initiative (IAVI) is to accelerate the development and subsequent use of a safe, efficacious and affordable AIDS vaccine for the world, and particularly for those regions most affected by the epidemic; hence, IAVI's commitment to developing a vaccine in and for these regions of the world. The search for a preventive AIDS vaccine is not only an extremely complex scientific endeavour, but involves a myriad of social and political issues related to AIDS itself and to the conduction of clinical trials in resource-poor settings that make AIDS vaccine research particularly challenging.

Vaccine preparedness addresses many of these social and political issues with the objective of establishing clinical and social research capacity and preparing communities for preventive AIDS vaccine trials and subsequent access. Project staff and partners on the ground will work with researchers, policy makers, Community Advisory Boards, non-governmental organisations, community-based organisations, health professionals and other key stakeholders to identify and support specific activities in sufficient quantity and with high quality in order to prepare for AIDS vaccine trials which will include the delivery of comprehensive education on HIV and its prevention and referral services for care, treatment and support.

Altogether, vaccine preparedness activities will help to create a sustainable in-country commitment to vaccines and a sense of ownership, particularly in developing countries.

SESSION 8: IMMUNOLOGY, IMMUNE-BASED THERAPIES AND VACCINES

2004-11-14
PL8.3

Copyright © 2004 - Thomson ACUMED® All rights reserved. Thomson ACUMED® is an intelligent and innovative medical marketing and communications agency – a new division of The Gardiner-Caldwell Group Ltd, part of The Thomson Corporation, located in Tytherington, UK.

Reproduction of this abstract (other than one copy for personal reference) must be cleared through the authors.